Skip to content
ppharmaranks
Menu

KISQALI FEMARA CO-PACK (COPACKAGED) vs MYSOLINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. KISQALI FEMARA CO-PACK (COPACKAGED) and MYSOLINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
74/100

Pharmacy pays

~$4.37 /30
~$2.89 /30

Type

RX
RX

Active ingredient

LETROZOLE AND RIBOCICLIB SUCCINATE
PRIMIDONE

Dosage forms

Kit
Tablet

Drug class

—
Anti-Epileptic Agent

Boxed warning

None
None

Half-life

about 2 days (terminal elimination half-life)
—

Treats

—
Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

Frequently asked questions

Which is better-rated, Kisqali Femara Co-Pack (Copackaged) or Mysoline?

By our independent rating, Mysoline scores higher — 3.7 vs 3.5 out of 5 for Kisqali Femara Co-Pack (Copackaged). Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Kisqali Femara Co-Pack (Copackaged) or Mysoline?

Mysoline costs pharmacies less to acquire — about $2.89 vs $4.37 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Kisqali Femara Co-Pack (Copackaged) and Mysoline?

Kisqali Femara Co-Pack (Copackaged) contains Letrozole and Ribociclib Succinate, while Mysoline contains Primidone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.